Brown Shipley& CO LTD Harvard Bioscience Inc Transaction History
Brown Shipley& CO LTD
- $305 Billion
- Q1 2024
A detailed history of Brown Shipley& CO LTD transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Brown Shipley& CO LTD holds 4,103 shares of HBIO stock, worth $11,693. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,103
Previous 4,783
14.22%
Holding current value
$11,693
Previous $25.6 Million
21.16%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding HBIO
# of Institutions
92Shares Held
32.8MCall Options Held
4KPut Options Held
2.2K-
B. Riley Asset Management, LLC Dallas, TX2.83MShares$8.08 Million5.14% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$8.08 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$7.9 Million0.71% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.56MShares$7.29 Million1.17% of portfolio
-
Amh Equity LTD2.32MShares$6.62 Million10.16% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $119M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...